Philip I. Smith has been named vice president of corporate development at Vital Images. The position was created to drive growth through the development of strategic relationships that will broaden sales and marketing channels and integrate new
Philip I. Smith has been named vice president of corporate development at Vital Images. The position was created to drive growth through the development of strategic relationships that will broaden sales and marketing channels and integrate new technologies. Smith will also be charged with pursuing any merger and acquisition efforts undertaken by the company.
Smith is an 11-year veteran of corporate finance, strategic planning, and market development positions in medical technology companies. Prior to joining Vital Images, he worked for two early-stage medical technology companies: as president and CEO of Thermonix in Minneapolis, and as vice president of marketing and business development for Image-Guided Neurologics in Melbourne, FL. Smith was previously an investment banker in the medical technology group of the investment firm US Bancorp Piper Jaffray and held senior sales positions at GE Medical Systems.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.